Correlation Between Dyne Therapeutics and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Dyne Therapeutics and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyne Therapeutics and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyne Therapeutics and Cue Biopharma, you can compare the effects of market volatilities on Dyne Therapeutics and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyne Therapeutics with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyne Therapeutics and Cue Biopharma.
Diversification Opportunities for Dyne Therapeutics and Cue Biopharma
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Dyne and Cue is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Dyne Therapeutics and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Dyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyne Therapeutics are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Dyne Therapeutics i.e., Dyne Therapeutics and Cue Biopharma go up and down completely randomly.
Pair Corralation between Dyne Therapeutics and Cue Biopharma
Considering the 90-day investment horizon Dyne Therapeutics is expected to generate 0.67 times more return on investment than Cue Biopharma. However, Dyne Therapeutics is 1.49 times less risky than Cue Biopharma. It trades about -0.02 of its potential returns per unit of risk. Cue Biopharma is currently generating about -0.26 per unit of risk. If you would invest 3,078 in Dyne Therapeutics on August 29, 2024 and sell it today you would lose (155.00) from holding Dyne Therapeutics or give up 5.04% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dyne Therapeutics vs. Cue Biopharma
Performance |
| Timeline |
| Dyne Therapeutics |
| Cue Biopharma |
Dyne Therapeutics and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dyne Therapeutics and Cue Biopharma
The main advantage of trading using opposite Dyne Therapeutics and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyne Therapeutics position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| Dyne Therapeutics vs. Eliem Therapeutics | Dyne Therapeutics vs. Scpharmaceuticals | Dyne Therapeutics vs. Milestone Pharmaceuticals | Dyne Therapeutics vs. Seres Therapeutics |
| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |